Stock comparison
Definium Therapeutics, Inc. is 5.0x more valuable than Cronos Group Inc. by market capitalization ($5.21 B vs $1.04 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
DFTX is larger
Definium Therapeutics, Inc. is 5.0x more valuable than Cronos Group Inc. by market capitalization ($5.21 B vs $1.04 B).
Market value leader
DFTX
Definium Therapeutics, Inc. is 5.0x more valuable than Cronos Group Inc. by market capitalization ($5.21 B vs $1.04 B).
Profit leader
CRON
DFTX: -$183.79M vs CRON: -$2.90M.
| Metric | DFTX | CRON |
|---|---|---|
| Market cap | $5.21 B | $1.04 B |
| US-listed rank | #1389 | #2609 |
| Revenue (latest FY) | - | $146.59M |
| Net income (latest FY) | -$183.79M | -$2.90M |
| Net margin | - | -2.0% |
| P/E (trailing FY) | - | - |
| SEC filings | 445 | 481 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
Definium Therapeutics, Inc. is 5.0x more valuable than Cronos Group Inc. by market capitalization ($5.21 B vs $1.04 B).
Full pages: Definium Therapeutics, Inc. and Cronos Group Inc., or browse the full rankings.